Eli Lilly is building an insurmountable lead in GLP-1 drugs through superior clinical efficacy of tirzepatide, direct-to-employer distribution that bypasses pharmacy benefit managers, and a ...

Mon, March 16, 2026 at 3:19 PM UTC Coupled with its rival's partnership with Hims & Hers Health (NYSE:HIMS) to sell branded versions of the injectable and oral treatments, Lilly can’t afford to rest ...

Eli Lilly said its next-generation obesity drug retatutride cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight. The drug ...

Eli Lilly and Company (NYSE:LLY) is one of the best long term stocks to invest in according to billionaires. Eli Lilly and Company (NYSE:LLY) announced on March 16 positive topline results from the ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Eli Stowers didn't use Vanderbilt football's pro day as a second showcase point for the record-breaking performances at the 2026 NFL Scouting Combine. Less than a month removed from vertical leaping ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience. The ...

Eli Lilly boasts competitive margins by industry standards. Several initiatives could help the company improve on that front. Since 2020, Eli Lilly's gross and operating margins have improved ...

Video: Jacob Wallace on Iowa football's defensive backs room Video: Cam Buffington provides insight on Iowa football's linebacker room ...

Carol looks more like the bad guy with each passing moment. If she didn’t sucker Clark into setting the stage for Floyd’s death so that he’d look guilty and she wouldn’t, then DTF St. Louis is going ...